UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of The Securities and Exchange Act of 1934

 

Date of Report (Date of earliest event reported): June 8, 2021

 

SHINECO, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-37776   52-2175898
(State or other jurisdiction
of incorporation)
 

(Commission

File Number)

  (IRS Employer
Identification No.)

 

Room 1001, Building T5,
DaZu Square, Daxing District,
Beijing, People’s Republic of China
  100076
(Address of principal executive offices)   (Zip Code)

 

(+86) 10-58693193
(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock   TYHT   NASDAQ Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company [X]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

 

 

 

 
 

 

Item 1.01 Entry into a Material Definite Agreement.

 

Entry into Restructuring Agreement

 

On June 8, 2021, Beijing Tenet-Jove Technological Development Co., Ltd. (“Tenet-Jove”), a wholly-owned subsidiary of Shineco, Inc. (the “Company”), entered into a Restructuring Agreement (the “Restructuring Agreement”) with the following parties:

 

  Ankang Longevity Pharmaceutical (Group) Co., Ltd. (“Ankang Longevity”), a company incorporated under the laws of the People’s Republic of China (the “PRC”);
     
  Mr. Jiping Chen, who is a minority shareholder of the Company and holds 68.7% of the equity interests in Ankang Longevity, and Ms. Xiaoyan Chen, who holds 31.3% of the equity interests in Ankang Longevity (collectively, the “Ankang Shareholders”);
     
  Yushe County Guangyuan Forest Development Co., Ltd., a company incorporated under the laws of the PRC (“Guangyuan”); and
     
  Mr. Baolin Li, who is currently a minority shareholder of the Company and holds 90% of the equity interests in Guangyuan, and Ms. Yufeng Zhang, who holds 10% of the equity interests in Guangyuan (collectively, the “Guangyuan Shareholders”).

 

Subject to the Restructuring Agreement and pursuant to certain Powers of Attorney dated December 31, 2008, in which the Ankang Shareholders irrevocably authorized Tenet-Jove to act on their behalf as their exclusive agent and attorney with respect to all rights as shareholders in Ankang Longevity, all parties agree to take certain actions, as described below, in furtherance of the restructuring:

 

  The Company will transfer all of its rights and interests in Ankang Longevity to the Guangyuan Shareholders in exchange for the control of 100% of equity interests and assets in Guangyuan;
     
  Tenet-Jove will enter a Termination Agreement with Ankang Longevity and the Ankang Shareholders; as a result, the Company, through Tenet-Jove, will release all equity interests in Ankang Longevity and release the Ankang Shareholders of their equity pledges. See “Item 1.02 Termination of a Material Definite Agreement” for more details;
     
  As a consideration to the Restructuring Agreement, Tenet-Jove will relinquish all of its rights and interests in Ankang Longevity and transfer those rights and interests to Guangyuan; and
     
  As a condition to closing, Guangyuan will enter into a series of agreements with Tenet-Jove. See “Entry into Guangyuan Variable Interest Entity Agreements” below. Furthermore, Guangyuan will enter a series of agreements, including Exclusive Purchase of Rights Agreement, Exclusive Business Cooperation Agreement, Equity Interest Pledge Agreement, and Powers of Attorney with Ankang Longevity and the Ankang Shareholders.

 

The foregoing description of the Restructuring Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Restructuring Agreement, which is filed as Exhibit 10.1 and is incorporated herein by reference.

 

Entry into Guangyuan Variable Interest Entity Agreements

 

On June 8, 2021, in connection with the Restructuring Agreement, the Company, through Tenet-Jove, entered into a series of contractual arrangements with Guangyuan and the Guangyuan Shareholders, known as Guangyuan Variable Interest Entity Agreements (the “Guangyuan VIE Agreements”). Due, in part, to regulations on foreign ownership of businesses in the PRC, neither the Company nor its subsidiaries own any equity interests in Guangyuan. Instead, the Company will control and receive the economic benefits of Guangyuan’s business operations through the Guangyuan VIE Agreements.

 

 
 

 

Each of the Guangyuan VIE Agreements is described below, including (a) Exclusive Business Cooperation Agreement, (b) Equity Interest Pledge Agreements, (c) Exclusive Option Agreements, and (d) Powers of Attorney with the Guangyuan Shareholders. As an overview, the Guangyuan VIE Agreements, in whole, are designed to allow the Company to manage the operations of Guangyuan and to receive 100% of the net income from Guangyuan. Furthermore, to secure the Company’s interest in Guangyuan, the Equity Interest Pledge Agreements, Exclusive Option Agreements, and Powers of Attorney are designed to allow the Company to step in and convert its contractual interests to equity interests in the event that the Company determines that doing so is warranted.

 

The Guangyuan VIE Agreements will remain in effect until the Company, through Tenet-Jove, unilaterally terminates the agreements.

 

The following is a summary of the contractual arrangements that provide the Company with effective control of Guangyuan and that enables the Company to receive economic benefits from its operations.

 

Exclusive Business Cooperation Agreement

 

On June 8, 2021, Tenet-Jove entered into an Exclusive Business Cooperation Agreement (“EBC Agreement”) with Guangyuan and the Guangyuan Shareholders. Guangyuan’s principal businesses include landscaping, afforestation, road greening, scenic greening, garden engineering, landscaping construction, and green afforestation. Tenet-Jove agrees to utilize its advantages in technology, human resources, and information and provides Guangyuan with technical supports, consulting services, and other management services relating to its day-to-day business operations and managements on an exclusive basis. Additionally, Guangyuan has granted an irrevocable and exclusive option to Tenet-Jove to purchase any or all of its assets, to the extent permitted by PRC laws. Tenet-Jove may exercise, at its sole discretion, the option to purchase from Guangyuan any or all assets at the lowest purchase price permitted by PRC laws. Should Tenet-Jove exercise such option, the parties shall enter into a separate asset transfer or similar agreement. Tenet-Jove shall own all intellectual property rights that are developed during the course of the EBC Agreement. For services rendered to Guangyuan by Tenet-Jove, Guangyuan agrees to pay a service fee to Tenet-Jove each month including management and service fees. Additionally, in the event that Tenet-Jove transfers technology rights to Guangyuan, Guangyuan will delegate those rights or acts to develop software or technology. In the event that Tenet-Jove leases equipment or properties to Guangyuan, any fee, rent, or pricing will be determined by Tenet-Jove on a case-by-case scenario.

 

The EBC Agreement shall commence on the effective date and remain in effect until Tenet-Jove terminates this agreement in writing.

 

The foregoing description of the EBC Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the EBC Agreement, which is filed as Exhibit 10.2 and is incorporated herein by reference.

 

Equity Interest Pledge Agreements

 

On June 8, 2021, Tenet-Jove entered into two separate Equity Interest Pledge Agreements with Guangyuan and the Guangyuan Shareholders. The Guangyuan Shareholders agreed to pledge certain portion of their equity interests in Guangyuan to Tenet-Jove to guarantee the performance of obligations under the EBC Agreement. Furthermore, Tenet-Jove is entitled to receive dividends and the Guangyuan Shareholders will only be able to receive dividends under the written permission of Tenet-Jove. In the event of a breach, Tenet-Jove, as pledgee, will be entitled to execute certain rights, including the right to collect any and all generated dividends and the right to dispose of the pledged equity interest in accordance with applicable PRC laws. The Guangyuan Shareholders further agreed not to dispose of the pledged equity interests or take any actions that would prejudice Tenet-Jove’s interest in Guangyuan.

 

Each Equity Interest Pledge Agreement will remain in effect until all payments are due under the EBC Agreement and have been paid by all parties. Tenet-Jove reserves the right to cancel or terminate the Equity Interest Pledge Agreement upon a full payment of fees.

 

The foregoing description of the Equity Interest Pledge Agreements does not purport to be complete and is qualified in its entirety by reference to the full text of the Equity Interest Pledge Agreements, which are filed as Exhibits 10.3 and 10.4 and are incorporated herein by reference.

 

 
 

 

Exclusive Option Agreements

 

On June 8, 2021, Tenet-Jove entered into two separate Exclusive Option Agreements with Guangyuan and the Guangyuan Shareholders. Under both agreements, each of the Guangyuan Shareholders irrevocably granted Tenet-Jove (or its designee) an exclusive option to purchase, to the extent permitted under PRC laws, once or at multiple times, at any time, part or all of their equity interests. The option price is equal to the capital paid in by the Guangyuan Shareholders, subject to any appraisal or restrictions required by applicable PRC laws. The option purchase price shall increase in the event that the Guangyuan Shareholders make additional capital contributions.

 

The Exclusive Option Agreements shall commence on the effective date and remain in effect until all equity interests held by the Guangyuan Shareholders have been transferred or assigned to Tenet-Jove or its designee.

 

The foregoing description of the Exclusive Option Agreements does not purport to be complete and is qualified in its entirety by reference to the full text of the Exclusive Option Agreements, which are filed as Exhibits 10.5 and 10.6 and are incorporated herein by reference.

 

Powers of Attorney

 

Under the Powers of Attorney executed between Tenet-Jove and the Guangyuan Shareholders, dated June 8, 2021, the Guangyuan Shareholders authorized Tenet-Jove to act on their behalf as their exclusive agent and attorney with respect to all matters concerning their rights as shareholders in Guangyuan, including: (1) attending shareholders’ meetings; (2) exercising all shareholder’s rights and voting rights under the PRC laws and the Guangyuan’s Articles of Association, including the sale, transfer, pledge, or disposition of shares, in part or in whole; and (3) designate and appoint legal representative, directors, supervisors, chief executive officer and other senior management members of Guangyuan.

 

The foregoing description of the Powers of Attorney does not purport to be complete and is qualified in its entirety by reference to the full text of the Powers of Attorney, which are filed as Exhibits 10.7 and 10.8 and are incorporated herein by reference.

 

Item 1.02 Termination of a Material Definitive Agreement.

 

On December 31, 2008, Tenet-Jove entered a series of variable interest agreements with Ankang Longevity and the Ankang Shareholders (the “Ankang VIE Agreements”), including an Executive Business Cooperation Agreement, an Equity Interest Pledge Agreement, an Executive Option Agreement, and Powers of Attorney. On July 3, 2014, Tenet-Jove entered a Timely Reporting Agreement with Ankang Longevity. For detailed descriptions of the Ankang VIE Agreements, refer to the Annual Report on 10-K filed on September 28, 2020.

 

On June 8, 2021, Tenet-Jove entered into a Termination Agreement with Ankang Longevity and the Ankang Shareholders (the “Termination Agreement”), pursuant to which Tenet-Jove would no longer have the rights to control Ankang Longevity and receive economic benefits from assets and properties, revenue, and net income of Ankang Longevity. Furthermore, Tenet-Jove would release the Ankang Shareholders of their equity pledges.

 

The foregoing description of the Termination Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Termination Agreement, which is filed as Exhibit 10.9 and is incorporated herein by reference.

 

 
 

 

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

 

(c) Exhibits

 

Exhibit Number  

Description

10.1   English translation of the Restructuring Agreement, dated June 8, 2021, by and among the Company, Tenet-Jove, Ankang Longevity, the Ankang Shareholders, Guangyuan, and the Guangyuan Shareholders
10.2   Exclusive Business Cooperation Agreement, dated June 8, 2021, by and between Tenet-Jove and Guangyuan
10.3   Equity Interest Pledge Agreement, dated June 8, 2021, by and among Tenet-Jove, Guangyuan, and the Guangyuan Shareholder (Baolin Li)
10.4   Equity Interest Pledge Agreement, dated June 8, 2021, by and among Tenet-Jove, Guangyuan, and the Guangyuan Shareholder (Yufeng Zhang).
10.5   Exclusive Option Agreement, dated June 8, 2021, by and among Tenet-Jove, Guangyuan, and the Guangyuan Shareholder (Baolin Li)
10.6   Exclusive Option Agreement, dated June 8, 2021, by and among Tenet-Jove, Guangyuan, and the Guangyuan Shareholder (Yufeng Zhang)
10.7   Power of Attorney, dated June 8, 2021, by and between the Guangyuan Shareholder (Baolin Li) and Tenet-Jove
10.8   Power of Attorney, dated June 8, 2021, by and between the Guangyuan Shareholder (Yufeng Zhang) and Tenet-Jove
10.9   English translation of the Termination Agreement, dated June 8, 2021, by and among Tenet-Jove, Ankang Longevity, and the Ankang Shareholders

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: June 11, 2021 Shineco, Inc.
     
  By: /s/ Yuying Zhang
   

Yuying Zhang

Executive Director

 

 

 

Exhibit 10.1

 

Among

 

Shineco Inc.

 

Beijing Tenet Jove Technological Development Co., Ltd.

 

Ankang Changshou Pharmaceutical Group

 

Jiping Chen

 

Xiaoyan Chen

 

And

 

Yushe County Guangyuan Forest Development Co., Ltd.

 

Baolin Li

 

Yufeng Zhang

 

 

 

Restructuring Framework Agreement

 

 

 

Date: June 8, 2021

 

 

 

 

Restructuring Framework Agreement

 

This Restructuring Framework Agreement (this “Agreement”) is made and entered into by and among the following parties on June 8, 2021.

 

(1) Shineco Inc., a company established and validly existing under the laws of the State of Delaware, the address is 15 Northeast Avenue, Dover, Kent, Delaware (“Listed Company”);

 

(2) Beijing Tenet Jove Technological Development Co., Ltd., a company established and validly existing under the laws of People’s Republic of China, the address is No.1008, Floor 9, Building 1, No. 2 Yard, Boxing 9th Road, Economic and Technological Development Zone, Beijing; (“Tenet Jove”)

 

(3) Ankang Changshou Pharmaceutical Group, a company established and validly existing under the laws of People’s Republic of China, the address is No. 31, Daqiao Road, Ankang City, Shaan Xi Province; (“Ankang”)

 

(4) Jiping Chen, ID number is [*], the contact address is [*];

 

(5) Xiaoyan Chen, ID number is [*], the contact address is [*] (collectively referred to as “Ankang Shareholders” with Jiping Chen);

 

(6) Yushe County Guangyuan Forest Development Co., Ltd., a company established and validly existing under the laws of People’s Republic of China, the address is Zhaojia Village, Haobei Town, Yushe County, Jinzhong City, Shanxi Province;

 

(7) Baolin Li, ID number is [*], the contact address is [*];

 

(8) Yufeng Zhang, ID number is [*], the contact address is [*].

 

Each of above Parties shall be referred to as a “Party” respectively, and they shall be collectively referred to as the “Parties”.

 

Whereas,

 

1. The Listed Company is a company listed on the Nasdaq Stock Exchange in the United States, under the code NASDAQ: TYHT.

 

2. Tenet Jove is a wholly-owned subsidiary established in Beijing by the Listed Company.

 

3. Ankang and Ankang Shareholders signed a full set of VIE agreements (including Exclusive Option Agreement, Exclusive Business Cooperation Agreement, Equity Interest Pledge Agreement, and Power of Attorney) with Tenet Jove on December 31, 2008, and the Listed Company owns 100 % Control right of Ankang (“VIE Agreements”).

 

4. Baolin Li holds 90% shares of Guangyuan, and Yufeng Zhang holds 10% shares of Guangyuan.

 

5. The Parties agree to reorganize the Listed Company (as defined above) in accordance with this agreement (“this Restructuring”).

 

In consideration of the mutual covenants and agreements set forth in this Agreement, the Parties hereto agree as follows:

 

 

 

 

Article 1 This Restructuring arrangement

 

1.1 Restructuring Steps

 

The parties confirm that the parties should carry out the Listed Company restructuring in accordance with the following agreement. Ankang will be separated from the Listed Company and a certain proportion of the assets of Guangyuan with the same value as the divested Ankang assets will be merged into the Listed Company (“Restructuring”) :

 

1.1.1 The Listed Company will file the restructuring documents in accordance with the requirements of the SEC and the Nasdaq Exchange and obtain the approval of the relevant authorities;

 

1.1.2 The Listed Company and the third-party independent professional agency hired by it shall do the due diligence on all the commercial, financial and legal aspects of Guangyuan, and then they will evaluate the assets of Guangyuan and Ankang, and issue the evaluation reports;

 

1.1.3 Ankang and Ankang Shareholders and Tenet Jove shall sign the termination agreement of VIE Agreements, release all the equity of Ankang held by the Listed Company and the equity pledge;

 

1.1.4 The Listed Company will obtain the certain proportion of the assets of Guangyuan with the same or a greater value as the divested Ankang assets the Listed Company held through sighing VIE agreement or an equity transfer agreement by Guangyuan, Guangyuan Shareholders and Tenet Jove /the Listed Company (the calculation of the ratio is based on the financial statements, audit reports and asset evaluation reports of Guangyuan and Ankang as stipulated in Article 1.1.2, and the final data shall be confirmed by all parties after necessary adjustments);

 

1.1.5 The way of the Listed Company to obtain equity control rights of Guangyuan shall be based on the documents ultimately signed by Guangyuan, the Guangyuan Shareholders and the Listed Company /Tenet Jove.

 

1.2 Restructuring Consideration

 

1.2.1 The Listed Company transfers all the rights of Ankang which acquired through the VIE agreements to Guangyuan shareholders as the consideration for this restructuring;

 

1.2.2 In order to obtain all the rights and interests of Ankang held by the Listed Company, Guangyuan shareholders shall sign the VIE Agreements (including Exclusive Option Agreement, Exclusive Business Cooperation Agreement, Equity Interest Pledge Agreement, and Power of Attorney) with Ankang and Ankang Shareholders and according to the above Equity Interest Pledge Agreement to handle equity pledge registration. Ankang and Ankang Shareholders shall cooperate with the above matters;

 

1.2.3 The consideration for this restructuring is based on the asset appraisal report of Guangyuan and Ankang as stipulated in Article 1.1.2.

 

 

 

 

1.3 Reasons for the Restructuring

 

The three-year development plan of the Listed Company has clarified the industrial development direction of “one core and two main” industries, mainly to develop the two major industries of comprehensive utilization of industrial hemp and prefabricated construction, and replace the planting of traditional Chinese medicine and the processing of decoction pieces with forest companies to ensure prefabricated building materials. Raw material, industrial hemp rod is not only the raw material for processing hemp fiber, but also the rod core can be reused into wall panels.

 

At present, the main business of industrial hemp of listed companies is not closely related to the processing of traditional Chinese medicine decoction pieces, and there is no complementarity with the main industry. Therefore, the concentrated development of industrial hemp business and the final industrialization must adjust the structure as soon as possible.

 

The annual pruning of the quick-grown willows of Guangyuan can meet the supply of prefabricated raw materials, greatly reduce the cost of raw materials and improve economic efficiency. In line with the concept of green development, it can be supported by national industrial policies and strengthen the company’s economic competitiveness.

 

Article 2 the Condition of Restructuring

 

The Parties confirmed that the conditions of the Restructuring are as follows:

 

2.1 The statements and guarantees made by the parties in Article 3 of this agreement shall remain true, accurate, complete and not misleading from the date hereof until the date of completion of Restructuring (including the date of completion of restructuring);

 

2.2 All parties have fulfilled or complied with their commitments, obligations and agreements that should be fulfilled on or before the date of completion of the Restructuring under this agreement;

 

2.3 The Listed Company has completed all the commercial, financial and legal due diligence of Guangyuan related to this Restructuring, and the Listed Company shall satisfy with the results of the due diligence;

 

2.4 The Listed Company has obtained the necessary approvals from its board of directors for this restructuring;

 

2.5 Guangyuan and Chengdu Zhongteng Fortune Industrial Co., Ltd. (hereinafter referred to as “Zhongteng”) signed the Cooperation Intent Agreement on May 16, 2019(hereinafter referred to as the “Cooperation Agreement”). Because it is currently unable to get in touch with Zhongteng and sign the termination agreement of the Cooperation Agreement. Zhongteng guarantees that Guangyuan has never performed and will not perform the cooperation agreement within the validity period of the cooperation agreement, and Guangyuan and Zhongteng do not have any unresolved claims and debts;

 

2.6 As its expired Land Contract Management Rights Contracts, Guangyuan shall renew the contracts and the land management rights held by Guangyuan shall not less than five years;

 

 

 

 

2.7 There are no disputes, potential disputes and defects regarding all land contractual management rights held by Guangyuan;

 

2.8 Before the completion of the Restructuring, Guangyuan did not have any significant adverse effects on its business operations, technology, finance, management and legal status;

 

2.9 From the date hereof until immediately prior to the date of completion of the restructuring, Guangyuan shall not have the following circumstances: (1) the actual controller of Guangyuan changes; (2) the main business and operation of Guangyuan undergo major changes; (3) Guangyuan divests its assets; (4) Guangyuan distributes its net profit;

 

2.10 Guangyuan has fully disclosed its business risks, legal disputes, mortgage guarantees, debts and affiliated parties’ relationship to other Parties.

 

Article 3 Representations and Warranties

 

3.1 Representations and warranties of the Listed Company and Tenet Jove

 

As the date hereof, the Listed Company and Tenet Jove jointly made the following statements and guarantees to other parties:

 

3.1.1 They have full capacity for civil conduct and civil rights to sign this agreement and perform their obligations under this agreement. They have obtained necessary authorization for signing this agreement and performing all obligations under this agreement. This agreement shall be legally binding on them.

 

3.1.2 The signing and performance of this agreement shall not violate the contract or agreement that it has entered in or is binding on them.

 

3.1.3 They shall make best effort to promote the restructuring under the agreement, and will not take any act or omission to hinder or improperly delay the restructuring under this agreement. In order to perform any provision of this agreement, they shall take all necessary actions and sign all necessary documents and instruments.

 

3.2 Representations and warranties of Ankang and Ankang Shareholders

 

As the date hereof, Ankang and its shareholders jointly made the following statements and guarantees to other parties regarding:

 

3.2.1 They have full capacity for civil conduct and civil rights to sign this agreement and perform their obligations under this agreement. They have obtained necessary authorization for signing this agreement and performing all obligations under this agreement. This agreement shall be legally binding on them.

 

3.2.2 The signing and performance of this agreement shall not violate the contract or agreement that it has entered in or is binding on them.

 

3.2.3 They shall make best effort to promote the restructuring under the agreement, and will not take any act or omission to hinder or improperly delay the restructuring under this agreement. In order to perform any provision of this agreement, they shall take all necessary actions and sign all necessary documents and instruments.

 

 

 

 

3.3 Representations and warranties of Guangyuan and its shareholders

 

As the date hereof, Guangyuan and its shareholders jointly made the following statements and guarantees to other parties:

 

3.3.1 They have full capacity for civil conduct and civil rights to sign this agreement and perform their obligations under this agreement. They have obtained necessary authorization for signing this agreement and performing all obligations under this agreement. This agreement shall be legally binding on them.

 

3.3.2 The signing and performance of this agreement shall not violate the contract or agreement that it has entered in or is binding on them.

 

3.3.3 They shall make best effort to promote the restructuring under the agreement, and will not take any act or omission to hinder or improperly delay the restructuring under this agreement. In order to perform any provision of this agreement, they shall take all necessary actions and sign all necessary documents and instruments.

 

3.3.4 Guangyuan and its shareholders shall not engage in, allow or promote any act or omission that would constitute or cause the statement, representations or warranties made in Article 3.2 to be untrue, inaccurate or violated.

 

3.3.5 Guangyuan and its shareholders shall take all reasonable efforts to preserve and protect Guangyuan’s assets, operate the main business of Guangyuan and maintain relationships with suppliers, partners, customers and employees in a manner consistent with past and prudent business practices, and shall ensure the normal operations of Guangyuan and that there will be no changes in the goodwill and operations of Guangyuan that will cause significant adverse effects. The “significant adverse effects” under this agreement refers to any of the following circumstances, changes, or impacts involving Guangyuan or its main business, and such conditions, changes or impacts (a) affect the existence, business, core assets, liabilities, and Key employees, business performance, or financial conditions are caused by, or there is sufficient evidence to show that it may cause serious adverse effects; or (b) the qualification, government approval, license, license or ability of Guangyuan’s current business is generated, or there is sufficient evidence to show that it may cause serious adverse effects; or (c) it has caused or has sufficient evidence to show that it may have a serious adverse effect on the performance of the main obligations under the transaction documents of Guangyuan, or has a serious adverse effect on the validity or enforceability of any transaction document, or has sufficient evidence to show that it may have a serious adverse effect.

 

3.3.6 Guangyuan and its shareholders grant the Listed Company (and its designated third-party intermediaries) the right to contact Guangyuan’s creditors, customers, partners, financial advisers, accountants and other advisors, and shall assist the Listed Company in obtaining the relevant information that related to this Restructuring, such as finance, operations and business information of Guangyuan, at its reasonable request (including but not limited to fully providing all necessary accounts, records, contracts, technical information, personnel information, management status and other documents related to the restructuring of Guangyuan to the lawyers, accountants, appraisers and other representatives appointed by the Listed Company). In addition, Guangyuan and its shareholders shall immediately notify the Listed Company of any litigation, arbitration or administrative procedures related to Guangyuan or its assets, business and/or income that have occurred or may occur. The access rights provided to the listed company under this agreement and the review of the information provided by the listed company will not affect or restrict any statements and guarantees made by Guangyuan and its shareholders under this agreement in any way.

 

 

 

 

3.3.7 In addition to the discussions on the transactions under this agreement, Guangyuan and its shareholders agree that from the date hereof until (a) the date of completion of the restructuring, or (b) the termination of this agreement (with the earlier occurrence shall prevail), Guangyuan and its shareholders and any of its affiliates, officers, directors, representatives or agents shall not (i) solicit, initiate, consider, encourage or accept any proposal or offer made by any subject regarding the following matters: (A) in connection with any acquisition or other acquisition of all or any part of Guangyuan’s equity, or the acquisition or other acquisition of Guangyuan’s assets, (B) any merger, merger or other business alliance with Guangyuan, (C) carry out capital restructuring, structural restructuring or any other abnormal business transactions involving Guangyuan, or (ii) participate in any discussion, conversation, negotiation and other exchanges on the foregoing matters, or provide any other subject with any information related to the foregoing matters, or cooperate, assist or participate in any other way, facilitate or encourage any other subject to attempt to proceed any effort or attempt on the foregoing matters. Guangyuan and its shareholders themselves shall immediately cease, and shall prompt the termination of all existing discussions, conversations, negotiations and other exchanges with any subject on any of the foregoing matters before this agreement. If any such proposal or offer related to the foregoing matters is made or received, or any inquiry or other contact with any subject regarding the foregoing matters, Guangyuan and its shareholders shall immediately notify the listed company.

 

3.3.8 If any event that may cause a material adverse effect occurs before the completion date of the restructuring, Guangyuan and its shareholders shall accurately and completely disclose to the listed company within five (5) working days after the occurrence of the relevant event.

 

Article 4 Termination

 

4.1 Condition

 

This agreement can be terminated in the following ways:

 

4.1.1 The parties can jointly terminate this agreement by a written agreement.

 

4.1.2 This agreement shall be terminated, if:

 

(1) One party to this agreement has breached the contract, and such breaches have materially affected the continued performance of this agreement, and the breaching party has not corrected the breach within thirty (30) days after receiving the notice of the observant party’s request for correction. The observant party has the right to terminate this agreement;

 

(2) Due to any major changes in applicable laws or their interpretations, or any government agency’s revision, supplementation or cancellation of applicable laws or their interpretations, the main purpose under this agreement cannot be achieved.

 

4.2 Effect of Termination

 

4.2.1 Unless otherwise specified, If validly terminated pursuant to the above clauses, this Agreement shall forthwith become null and void and of no further force and effect, other than the Articles 5, 6, 7, 8, 9, and 10, all of which shall survive termination of this Agreement.

 

 

 

 

4.2.2 Unless otherwise specified, after the termination of this agreement, the parties to this agreement shall try their best to restore the state when this agreement was signed based on the principles of fairness, reasonableness, and good faith. Such termination shall not affect any party’s right or relief to obtain compensation or compensation under this agreement.

 

Article 5 Liability for the breach

 

5.1 Any party has violated any guarantee, promise, agreement or any other provisions under this agreement, or any statement made by any party under this agreement is untrue, incomplete or misleading (“Breach”, the party in breach is hereinafter referred to as the “defaulting party”), thereby causing other parties to bear any costs, liabilities or losses (Including but not limited to the actual losses suffered by the other party, as well as reasonable evidence to prove any loss of profit expected to be obtained, any interest paid or lost, arbitration fees, attorney fees and all deprived benefits, collectively referred to as “compensable loss”), the breaching party shall compensate the other party for all the aforementioned compensable losses.

 

5.2 After the completion of due diligence and asset evaluation, except for reasons that the results of due diligence and asset evaluation are not satisfactory to the listed company, if the restructuring cannot be carried out due to the reasons of Guangyuan and/or the shareholders of Guangyuan, Guangyuan shall bear any expenses that the listed company has already invested in all asset evaluations, due diligence, and reasonable evidence to prove that the listed company has invested in the restructuring for the inability to carry out the restructuring.

 

Article 6 Force Majeure

 

6.1 Definition of force majeure

 

Force majeure refers to an objective situation that cannot be foreseen, unavoidable, and cannot be overcome, including due to earthquakes, typhoons, floods, fires, wars, and other force majeure events that cannot be foreseen and whose occurrence and consequences cannot be prevented or avoided, or any changes in laws, regulations, and regulations, or the promulgation of new laws, regulations, and regulations, or any government action, it affects the performance of this agreement or cannot be performed as agreed.

 

6.2 Effect of force majeure

 

6.2.1 If force majeure occurs and a party affects its performance of any obligations under this agreement due to force majeure, the performance of such obligations shall be suspended during that period, which period of delay in fulfilling the obligations related to this agreement due to force majeure, and the performance deadline shall be extended accordingly in accordance with the delay in the performance of the obligation without any penalty. The party claiming force majeure shall use both mail and express delivery within seven (7) working days after the occurrence of the force majeure, or within seven (7) working days of the restoration of the telecommunications conditions in the case of a telecommunications interruption , to notify the other parties of the details of the force majeure, and provide proof of the occurrence and duration of the force majeure, and at the same time, try to resume the performance of the obligations that are delayed or hindered due to the force majeure in the shortest possible time.

 

 

 

 

6.2.2 If the party claiming force majeure fails to notify the other parties and provide appropriate certification in accordance with the above provisions, it shall not be exempt from the responsibility for failure to perform or delay in performing the obligations under this agreement. The party affected by the force majeure shall make reasonable efforts to reduce the consequences caused by the force majeure, and resume all relevant obligations as soon as possible after the force majeure is terminated. If the party affected by the force majeure fails to resume the performance of the obligations after the reason for suspending the performance of the obligations due to the force majeure disappears, the party shall be liable to the other parties for this.

 

6.2.3 When force majeure occurs, the parties should immediately negotiate with each other to reach a fair solution, and must make all reasonable efforts to minimize the consequences of the force majeure.

 

Article 7 Confidentiality

 

7.1 Scope of confidentiality

 

The parties agree to keep the following information confidential: the existence, content and signature of this agreement and its attachments, the trade secrets and technical secrets of the other party learned by each party during the validity period of this agreement and its annexes, as well as any oral or written information exchanged between each other in preparation or performance of this agreement, and other matters that require the parties to keep confidential (“Confidential Information”). It shall not be disclosed or disclosed to third parties without the written consent of other parties. Each party shall ensure that its employees, consultants, agents and their designated third-party intermediaries perform their confidentiality obligations under this agreement. However, the disclosure of confidential information by either party under any of the following circumstances is not considered a violation of this agreement: (1) the information was known to the public at the time of disclosure; (2) the information was disclosed based on the other party’s prior written consent; (3) In order to evaluate the purpose of this restructuring, one party shall disclose to its shareholders, directors, supervisors, management members, or the accounting firm or law firm hired by it that agrees to perform confidentiality obligations; (4) one party makes disclosure in accordance with the requirements of the stock exchange, regulatory agency or other government agency that has jurisdiction over it, and the party prior to the disclosure first informs the other parties in writing of the exact nature and content of the disclosed confidential information. Within a reasonable time before the above disclosure is made, the disclosing party shall negotiate with other parties on the disclosure, and seek confidential treatment of the confidential information that needs to be disclosed as far as possible in accordance with the reasonable requirements of other parties.

 

7.2 Confidentiality period

 

The parties agree that, regardless of whether this agreement is changed, cancelled or terminated, Article 7 of this agreement will continue to be effective.

 

 

 

 

Article 8 Notice

 

8.1 Notification method

 

Any notices, arbitration documents or other judicial documents or other communications (“notices”) sent by one party to other parties related to this agreement shall be in written form (including but not limited to letters and emails). For the purpose of serving the notice, the contact information of the parties is shown in the annex to this agreement.

 

8.2 Delivery

 

The various written notices stipulated in the preceding paragraph shall determine their delivery time in the following ways:

 

(1) If the notice submitted in person is deemed to be served when the notified person signs for it, it shall not be deemed to have been effectively served if the notified person does not sign for it;

 

(2) All notices that can be sent by post shall be made by registered express mail or express mail, and shall be deemed to have been delivered to the notified person within seven (7) days after posting;

 

(3) Any notice sent by e-mail is deemed to have been effectively delivered to the notified person on the first working day after the notice reaches the recipient.

 

8.3 Address Modification

 

If any party’s contact information changes (“the changing party”), the changing party shall notify the other parties within seven (7) days after the change occurs. If the changing party fails to notify in time as agreed, the changing party shall bear the losses caused thereby.

 

Article 9 Dispute Resolution

 

9.1 Applicable law

 

The conclusion, validity, execution and interpretation of this agreement and the settlement of unresolved disputes shall be governed by Chinese law.

 

9.2 Dispute Resolution

 

9.2.1 Any disputes, disputes, disagreements or claims caused by or related to this agreement, including the existence, validity, interpretation, performance, violation or termination of this agreement, or any disputes arising from or related to this agreement, should be submitted to the Beijing Arbitration Commission for arbitration, and finally resolved in accordance with the effective arbitration rules of the Beijing Arbitration Commission when the notice of arbitration was submitted. The applicable law of this arbitration clause is Chinese law. The place of arbitration shall be Beijing. The arbitration proceedings shall be conducted in Mandarin.

 

9.2.2 The arbitration award is final and binding on all parties. The parties agree to be bound by the ruling and act in accordance with the ruling. Unless otherwise specified in the arbitration award, the arbitration costs and the execution costs of the arbitration award (including witness fees and attorney fees) shall be borne by the losing party. In the event of any unresolved dispute and if any unresolved dispute is under arbitration, except for the matters involved in the unresolved dispute, each party shall continue to exercise their remaining rights and perform their remaining obligations in accordance with this agreement.

 

 

 

 

Article 10 MISCELLANEOUS

 

10.1 Severability

 

10.1.1 If any one or more of the provisions of this agreement are determined to be invalid, illegal or unenforceable in any respect in accordance with applicable laws or regulations, the validity, legality or enforceability of the remaining provisions of this agreement shall not be affected or impaired. All parties should negotiate in good faith, replace those invalid, illegal or unenforceable regulations by effective regulations permitted by law and expected by all parties in best efforts. The commercial effects of such effective regulations should be similar to those of invalid, illegal or unenforceable regulations.

 

10.1.2 The terms and attachments of this agreement should be regarded as a part of this agreement. When referring to “this Agreement”, it should be understood to include its attachments.

 

10.2 Entire Agreement

 

10.2.1 This agreement and its annexes constitute the complete and only agreement reached by the parties regarding this restructuring, replace all verbal or written investment intents, agreements, understandings and communications, and any other related documents reached by the parties in relation to this restructuring before.

 

10.3 Entry into force, substitution and modification

 

10.3.1 This agreement will take effect from the date when all parties sign or seal it. The annex to this agreement has the same effect as this agreement. If there is a conflict between the attachment and the agreement of this agreement, this agreement shall prevail. For matters not covered in this agreement, the parties will negotiate separately and sign a supplementary agreement. The supplementary agreement has the same legal effect as this agreement.

 

10.3.2 Unless otherwise agreed in this agreement, amendments and changes to this agreement must be agreed upon by all parties, in written form, and become effective on the date they are signed or sealed by all parties.

 

10.4 Expenses bear

 

Unless otherwise agreed by the parties, each party shall bear its own costs, taxes and expenses related to this restructuring.

 

10.5 No Waiver

 

Unless otherwise provided in this agreement, the failure or delay of a party to exercise the rights, powers or privileges under this agreement does not constitute a waiver of these rights, powers and privileges, and the sole or partial exercise of these rights, powers and privileges does not exclude the exercise of any other Rights, powers and privileges.

 

10.6 Language and copy

 

This agreement can be signed in multiple copies, each with the same effect. The electronic version of the signed text of this agreement that the parties have confirmed and exchanged by email and stored in PDF format shall be regarded as the original, which can be used as a separate proof of the establishment and effectiveness of this agreement.

 

[Signature Pages Follow]

 

 

 

 

IN WITNESS WHEREOF, the Parties have caused their authorized representatives to execute this agreement as of the date first above written.

 

Shineco, Inc.  
     
By: /s/ Guocong Zhou  
Name: Guocong Zhou  
Title: Director  
     
Beijing Tenet Jove Technological Development Co., Ltd.  
     
By: /s/ Yuying Zhang  
Name: Yuying Zhang  
Title: Legal Representative  

 

 

 

 

 

IN WITNESS WHEREOF, the Parties have caused their authorized representatives to execute this agreement as of the date first above written.

 

Ankang Changshou Pharmaceutical Group,  
     
By: /s/ Jiping Chen  
Name: Jiping Chen  
Title: Legal Representative  
     
  /s/ Jiping Chen  
Name: Jiping Chen  
     
  /s/ Xiaoyan Chen  
Name: Xiaoyan Chen  

 

 

 

 

IN WITNESS WHEREOF, the Parties have caused their authorized representatives to execute this agreement as of the date first above written.

 

Yushe County Guangyuan Forest Development Co., Ltd.  
     
By: /s/ Baolin Li  
Name: Baolin Li  
Title: Legal Representative  
     
  /s/ Baolin Li  
Name: Baolin Li  
     
  /s/ Yufeng Zhang  
Name: Yufeng Zhang  

 

 

 

 

 

Exhibit 10.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exhibit 10.3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exhibit 10.4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exhibit 10.5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exhibit 10.6

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exhibit 10.7

 

 

 

 

 

 

 

 

 

 

 

 

Exhibit 10.8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exhibit 10.9

Termination Agreement

 

This Termination Agreement (this “Agreement”) is made and entered into by and among the following parties on June 8, 2021 in Beijing.

 

(1) Beijing Tenet Jove Technological Development Co., Ltd., a company established and validly existing under the laws of People’s Republic of China, the address is No.1008, Floor 9, Building 1, No. 2 Yard, Boxing 9th Road, Economic and Technological Development Zone, Beijing; (“WFOE”)

 

(2) Ankang Changshou Pharmaceutical Group, a company established and validly existing under the laws of People’s Republic of China, the address is No. 31, Daqiao Road, Ankang City, Shaan Xi Province; (“VIE Company”)

 

(3) Jiping Chen, ID number is [*], the contact address is [*];

 

(4) Xiaoyan Chen, ID number is [*], the contact address is [*] (collectively referred to as “the Shareholders” with Jiping Chen);

 

In this Agreement, VIE Company, WFOE and the Shareholders shall be referred to as a “Party” respectively, and they shall be collectively referred to as the “Parties”.

 

Whereas,

 

1. On December 31, 2008, VIE Company and WFOE signed the Exclusive Business Cooperation Agreement and Timely Reporting Agreement; VIE Company, WFOE and the Shareholders signed the Exclusive Option Agreement and Equity Interest Pledge Agreement, At the same time, the Shareholders respectively issued the Power of Attorney to the WFOE (the above documents are collectively referred to as the “VIE Agreements”).

 

2. The parties hereby agree to terminate all VIE Agreements in accordance with this agreement.

 

In consideration of the mutual covenants and agreements set forth in this Agreement, the Parties hereto agree as follows:

 

1. Termination of VIE Agreements

 

1.1 The parties hereby irrevocably agree and confirm that the VIE Agreements shall be terminated from the date hereof and no longer have any effect. And the parties shall immediately apply to the relevant industry and commerce administrative department to cancel the pledge registration.

 

1.2 As the date hereof, the parties no longer enjoy the rights under the VIE Agreements, and no longer need to perform the obligations under the VIE Agreements. The parties do not need to return the parts that have been performed by the parties based on the VIE Agreements.

 

 

 

 

1.3 The parties to this agreement hereby irrevocably and unconditionally waive any kind of disputes, claims, rights, obligations, responsibilities, actions, contracts or reasons for litigation, which directly or indirectly related to the VIE Agreements or arising from the VIE Agreements, owed or probably owed by other parties to this agreement in the past, present or future.

 

1.4 Without prejudice to the general application of Article 1.3 above, from the date hereof, the parties to this agreement hereby exempt the party, its heirs, successors, transferees or estate executors from any kind of commitments, debts, demands, requirements, obligations and responsibilities related to or arising from the VIE Agreement owned or probable owed by other parties to this agreement, the current and past directors, executives, employees, legal advisers and agents of these other parties, the related parties of these persons, and their respective successors and assigns, in the past, present or the future, including claims and reasons for litigation in law or based on the principle of equality, regardless of whether the requirements have been filed or not, absolute or contingent, known or unknown.

 

2. Representations and Warranties

 

Each party hereby, on the date hereof, collectively and individually represent and warrant to the other parties as follows:

 

2.1 It has obtained the necessary authorization and has the right to sign this agreement; its signing and performance of this agreement does not constitute a conflict, restriction or violation of laws, regulations or agreements that are binding or have an impact on it.

 

2.2 Once this agreement is signed, it constitutes a legal, effective, and binding obligation for all parties to enforce them in accordance with the terms of this agreement.

 

2.3 There is no litigation, arbitration, or legal, administrative or other procedures or government investigations related to the subject of this agreement.

 

3. Commitment

 

In order to successfully complete the termination of rights and obligations under the VIE Agreement, all parties should sign all necessary or appropriate documents, take all necessary or appropriate actions, and actively cooperate with other parties to obtain relevant government approval or/and registration documents, and handle relevant termination procedures.

 

4. Liability for breach

 

Any party who violates the provisions of this agreement and makes the whole or part of this agreement unable to perform shall be liable for the breach and compensate the other parties in this agreement for the losses suffered as a result.

 

5. Confidentiality

 

The parties acknowledge and confirm that any oral or written information exchanged between each other in relation to this agreement is confidential. The parties shall keep all such information confidential and shall not disclose any relevant information to any third party without the written consent of the other parties in this agreement, except in the following circumstances: (a) the public is aware of or will be aware of such information (and not disclosed to the public by the party receiving the information without authorization); (b) information required to be disclosed by applicable laws or regulations; or (c) the information that any party needs to disclose to its potential investor, legal or financial adviser in relation to the transactions described in this agreement, and the potential investor, legal or financial adviser shall also comply with confidentiality obligations similar to this clause. If any party’s staff or employing agency’s leaks are deemed to be that party’s leaks, it shall be liable for breach of contract in accordance with this agreement. Regardless of the termination of this agreement for any reason, this clause remains effective.

 

 

 

 

6. Applicable law and dispute resolution

 

6.1 The conclusion, validity, interpretation, performance, modification and termination of this agreement, and dispute resolution are all applicable to Chinese laws.

 

6.2 In the event of disputes, litigation claims, disputes, or breach, termination, or invalidity (“disputes”) concerning the interpretation or implementation of this agreement, the parties shall first resolve them through friendly negotiation. If either party issues a written notice requesting that the dispute be negotiated and the parties fail to resolve it through friendly negotiation, unless otherwise agreed in writing, such disputes shall be submitted to the China International Economic and Trade Arbitration Commission for arbitration in accordance with its then effective arbitration rules, and the place of arbitration shall be Beijing. Any arbitral decision made in accordance with the provisions of this article is final and binding on all parties.

 

6.3 When any dispute arises due to the interpretation and performance of this agreement or any dispute is undergoing arbitration, except for the matters in dispute, the parties to this agreement shall continue to exercise their other rights under this agreement and perform their other obligations under this agreement.

 

7. MISCELLANEOUS

 

7.1 This agreement will take effect immediately after the parties signed or sealed it on the date hereof at the beginning of this agreement.

 

7.2 This agreement can be signed in one or more originals, each of which has the same effect.

 

7.3 The parties to this agreement can modify and supplement this agreement through a written agreement. The modification agreement and/or supplementary agreement of the parties to this agreement are an integral part of this agreement and have the same legal effect as this agreement.

 

7.4 The invalidity or unenforceability of any clause under this agreement does not affect the legal validity of other clauses under this agreement.

 

[Signature Pages Follow]

 

 

 

 

IN WITNESS WHEREOF, the Parties have caused their authorized representatives to execute this agreement as of the date first above written.

 

Beijing Tenet Jove Technological Development Co., Ltd.  
     
By: /s/ Yuying Zhang  
Name: Yuying Zhang  
Title: Legal Representative  

 

 

 

 

IN WITNESS WHEREOF, the Parties have caused their authorized representatives to execute this agreement as of the date first above written.

 

Ankang Changshou Pharmaceutical Group,  
     
By: /s/ Jiping Chen  
Name: Jiping Chen  
Title: Legal Representative  
     
  /s/ Jiping Chen  
Name: Jiping Chen  
     
  /s/ Xiaoyan Chen  
Name: Xiaoyan Chen